These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34048879)

  • 1. Long-acting nanoparticle-loaded bilayer microneedles for protein delivery to the posterior segment of the eye.
    Wu Y; Vora LK; Wang Y; Adrianto MF; Tekko IA; Waite D; Donnelly RF; Thakur RRS
    Eur J Pharm Biopharm; 2021 Aug; 165():306-318. PubMed ID: 34048879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanosuspension-loaded dissolving bilayer microneedles for hydrophobic drug delivery to the posterior segment of the eye.
    Wu Y; Vora LK; Mishra D; Adrianto MF; Gade S; Paredes AJ; Donnelly RF; Singh TRR
    Biomater Adv; 2022 Jun; 137():212767. PubMed ID: 35929230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferasirox nanosuspension loaded dissolving microneedles for ocular drug delivery.
    Faizi HS; Nasiri MI; Wu Y; Mishra D; Donnelly RF; Minhas MU; Vora LK; Singh Thakur RR
    Int J Pharm; 2024 Oct; 664():124614. PubMed ID: 39168286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.
    Vora LK; Donnelly RF; Larrañeta E; González-Vázquez P; Thakur RRS; Vavia PR
    J Control Release; 2017 Nov; 265():93-101. PubMed ID: 29037785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapidly dissolving bilayer microneedles enabling minimally invasive and efficient protein delivery to the posterior segment of the eye.
    Wu Y; Vora LK; Donnelly RF; Singh TRR
    Drug Deliv Transl Res; 2023 Aug; 13(8):2142-2158. PubMed ID: 35713782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
    Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
    Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
    Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q
    Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microneedle array systems for long-acting drug delivery.
    Vora LK; Moffatt K; Tekko IA; Paredes AJ; Volpe-Zanutto F; Mishra D; Peng K; Raj Singh Thakur R; Donnelly RF
    Eur J Pharm Biopharm; 2021 Feb; 159():44-76. PubMed ID: 33359666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery.
    Thakur RR; Tekko IA; Al-Shammari F; Ali AA; McCarthy H; Donnelly RF
    Drug Deliv Transl Res; 2016 Dec; 6(6):800-815. PubMed ID: 27709355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microneedle scleral patch for minimally invasive delivery of triamcinolone to the posterior segment of eye.
    Roy G; Garg P; Venuganti VVK
    Int J Pharm; 2022 Jan; 612():121305. PubMed ID: 34800618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery.
    Tu J; Du G; Reza Nejadnik M; Mönkäre J; van der Maaden K; Bomans PHH; Sommerdijk NAJM; Slütter B; Jiskoot W; Bouwstra JA; Kros A
    Pharm Res; 2017 Aug; 34(8):1693-1706. PubMed ID: 28536970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment.
    Varshochian R; Riazi-Esfahani M; Jeddi-Tehrani M; Mahmoudi AR; Aghazadeh S; Mahbod M; Movassat M; Atyabi F; Sabzevari A; Dinarvand R
    J Biomed Mater Res A; 2015 Oct; 103(10):3148-56. PubMed ID: 25773970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication of Poly Lactic-
    Shrestha N; Karve T; Kipping T; Banga AK
    Mol Pharm; 2024 Oct; 21(10):5192-5204. PubMed ID: 39255036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
    Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
    Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
    [No Abstract]   [Full Text] [Related]  

  • 16. Chitosan-Polycaprolactone Core-Shell Microparticles for Sustained Delivery of Bevacizumab.
    Jiang P; Jacobs KM; Ohr MP; Swindle-Reilly KE
    Mol Pharm; 2020 Jul; 17(7):2570-2584. PubMed ID: 32484677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracorneal injection of a detachable hybrid microneedle for sustained drug delivery.
    Lee K; Song HB; Cho W; Kim JH; Kim JH; Ryu W
    Acta Biomater; 2018 Oct; 80():48-57. PubMed ID: 30267886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Transdermal Protein Delivery Strategy via Electrohydrodynamic Coating of PLGA Microparticles onto Microneedles.
    Angkawinitwong U; Courtenay AJ; Rodgers AM; Larrañeta E; McCarthy HO; Brocchini S; Donnelly RF; Williams GR
    ACS Appl Mater Interfaces; 2020 Mar; 12(11):12478-12488. PubMed ID: 32066234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal Vaccination with PLGA Nanoparticles via Dissolving Microneedles and Classical Injection Needles.
    Lee J; Neustrup MA; Slütter B; O'Mahony C; Bouwstra JA; van der Maaden K
    Pharm Res; 2024 Feb; 41(2):305-319. PubMed ID: 38332390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly bioactive, bevacizumab-loaded, sustained-release PLGA/PCADK microspheres for intravitreal therapy in ocular diseases.
    Liu J; Li S; Li G; Li X; Yu C; Fu Z; Li X; Teng L; Li Y; Sun F
    Int J Pharm; 2019 May; 563():228-236. PubMed ID: 30959236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.